Encompass Bioscience's Convertible Note Round

Encompass Bioscience raised a round of funding on July 26, 2017. Investors include Illumina Accelerator.

Encompass aims to integrate genetic information into the healthcare system in order to help better tailor treatment recommendations and guidelines for patients.…

Articles about Encompass Bioscience's Convertible Note Round: